(Q45888082)

17 December 2017

title

Dose-dependent improvements in outcome with adenoviral expression of interleukin-10 in a murine model of multisystem organ failure (English)

1 reference

17 December 2017

1 reference

1 reference

P F McAuliffe

1

1 reference

17 December 2017

M E Murday

2

1 reference

17 December 2017

P A Efron

3

1 reference

17 December 2017

P O Scumpia

4

1 reference

17 December 2017

R Ungaro

5

1 reference

17 December 2017

Amer Abouhamze

6

1 reference

17 December 2017

C L Tannahill

7

1 reference

17 December 2017

B Hutchins

8

1 reference

17 December 2017

D LaFace

9

1 reference

17 December 2017

L L Moldawer

10

1 reference

17 December 2017

language of work or name

1 reference

1 February 2006

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

13

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

276-282

1 reference

17 December 2017

Gene therapy for acute diseases

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Gene therapy progress and prospects: adenoviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Adenoviral vectors for gene transfer and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

First-generation adenovirus vectors shorten survival time in a murine model of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Clinical protocol: Phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Gene therapies for osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

TNF-alpha receptor signaling and IL-10 gene therapy regulate the innate and humoral immune responses to recombinant adenovirus in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Adenoviral delivery of human and viral IL-10 in murine sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Intrapulmonary tumor necrosis factor gene therapy increases bacterial clearance and survival in murine gram-negative pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

TGF-beta is a critical mediator of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Proinflammatory effects of IL-10 during human endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Methods for construction of adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

7 January 2021

Multiple-organ failure and sepsis without bacteria. An experimental model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

7 January 2021

Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

7 January 2021

Inhibition of tumor necrosis factor alpha by an adenovirus-encoded soluble fusion protein extends transgene expression in the liver and lung

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

7 January 2021

Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

7 January 2021

Interleukin-10 appearance following thoraco-abdominal and abdominal aortic aneurysm repair is associated with the duration of visceral ischaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

7 January 2021

Interleukin 10 mitigates the development of the zymosan-induced multiple organ dysfunction syndrome in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

7 January 2021

Tumour necrosis factor alpha (TNF-alpha) and interleukin 6 in a zymosan-induced shock model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

7 January 2021

A monoclonal antibody against tumour necrosis factor-alpha improves survival in experimental multiple organ dysfunction syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

7 January 2021

Paradoxical priming effects of IL-10 on cytokine production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

7 January 2021

Anti-interleukin-10 antibody restores burn-induced defects in T-cell function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302600

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302600

1 reference

17 December 2017

Dimensions Publication ID

1015463269

0 references

1 reference

17 December 2017